Processing

Please wait...

Settings

Settings

1. WO2000043018 - MEDICINAL COMPOSITIONS

Publication Number WO/2000/043018
Publication Date 27.07.2000
International Application No. PCT/JP2000/000184
International Filing Date 18.01.2000
Chapter 2 Demand Filed 07.06.2000
IPC
A61K 31/7004 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7004Monosaccharides having only carbon, hydrogen and oxygen atoms
A61K 31/7016 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7016Disaccharides, e.g. lactose, lactulose
A61K 31/702 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A61K 31/7024 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7024Esters of saccharides
A61K 31/7028 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
C07H 3/10 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
3Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
10Anhydrosugars, e.g. epoxides
CPC
A61K 31/7004
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7004Monosaccharides having only carbon, hydrogen and oxygen atoms
A61K 31/7016
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7016Disaccharides, e.g. lactose, lactulose
A61K 31/702
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
A61K 31/7024
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7024Esters of saccharides
A61K 31/7028
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
A61K 31/7048
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin ; digitoxin or digoxin
Applicants
  • TAKARA SHUZO CO., LTD. [JP/JP]; 609, Takenaka-cho, Fushimi-ku Kyoto-shi, Kyoto 612-8061, JP (AllExceptUS)
  • ENOKI, Tatsuji [JP/JP]; JP (UsOnly)
  • SAGAWA, Hiroaki [JP/JP]; JP (UsOnly)
  • TOMONO, Jun [JP/JP]; JP (UsOnly)
  • TOMINAGA, Takanari [JP/JP]; JP (UsOnly)
  • NISHIYAMA, Eiji [JP/JP]; JP (UsOnly)
  • WU, Hua-Kang [CA/JP]; JP (UsOnly)
  • KATO, Ikunoshin [JP/JP]; JP (UsOnly)
Inventors
  • ENOKI, Tatsuji; JP
  • SAGAWA, Hiroaki; JP
  • TOMONO, Jun; JP
  • TOMINAGA, Takanari; JP
  • NISHIYAMA, Eiji; JP
  • WU, Hua-Kang; JP
  • KATO, Ikunoshin; JP
Agents
  • AOYAMA, Tamotsu ; Aoyama & Partners IMP Building, 3-7, Shiromi 1-chome Chuo-ku Osaka-shi, Osaka 540-0001, JP
Priority Data
11/1164620.01.1999JP
11/19180806.07.1999JP
11/27028524.09.1999JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) MEDICINAL COMPOSITIONS
(FR) COMPOSITIONS MEDICAMENTEUSES
Abstract
(EN)
Medicinal compositions for treating or preventing diabetes, rheumatoid, diseases wherein inflammation should be inhibited, diseases wherein $g(a)-glycosidase should be inhibited, diseases wherein the synthesis of prostaglandin should be inhibited, diseases wherein endotoxin shock should be inhibited, diseases wherein the production of interleukin should be inhibited, diseases wherein the production of heme oxygenase should be induced, and diseases wherein the production of tumor necrosis factor or carcinogenesis should be inhibited, which contain as the active ingredient at least one compound selected from the group consisting of 3,6-anhydrogalactopyranose represented by formula (I), its aldehyde, its hydrate and 2-O-methylated derivatives and 2-O-sulfated derivatives thereof.
(FR)
L'invention concerne des compositions médicamenteuses permettant de traiter ou de prévenir les diabètes, les affections rhumatoïdes, les maladies dans lesquelles l'inflammation doit être inhibée, les maladies dans lesquelles l'alpha-glycosidase doit être inhibée, les maladies dans lesquelles la synthèse de la prostaglandine doit être inhibée, les maladies dans lesquelles le choc endotoxinique doit être inhibé, les maladies dans lesquelles la production de l'interleukine doit être inhibée, les maladies dans lesquelles de l'hème oxygénase doit être induite, et les maladies dans lesquelles la production du facteur de nécrose tumorale ou la carcinogenèse doit être inhibée. Ces compositions contiennent comme ingrédient actif au moins un composé sélectionné dans le groupe constitué par 3,6-anhydrogalactopyranose représenté par la formule (I), son aldéhyde, son hydrate, des dérivés 2-O-méthylés et des dérivés 2-O-sulfatés.
Latest bibliographic data on file with the International Bureau